Table 1.

EQ5D-3L health utilities in chronic hepatitis patients and results of regression analyses

Unadjusted Utilities	Estimate	Standard error	p-value†
All patients			0.0002*
Hospital setting (n = 113)	0.806	0.195
Community setting (n = 98)	0.722	0.209
No cirrhosis			0.0001*
Hospital setting (n = 77)	0.835	0.157
Community setting (n = 76)	0.732	0.200
Compensated cirrhosis			0.1901
Hospital setting (n = 36)	0.744	0.250
Community setting (n = 22)	0.686	0.238
Regression Model 1	Estimate	Standard error	p-value
Age	0.000	0.001	0.780
Sex (female)	–0.005	0.029	0.876
Liver disease severity: compensated cirrhosis	–0.066	0.032	0.040*
Charlson Comorbidity index
1	–0.072	0.038	0.062
2	–0.058	0.047	0.224
3+	–0.110	0.055	0.048*
Setting: community	–0.075	0.031	0.018*
Regression Model 2	Estimate	Standard error	p-value
Age	0.000	0.001	0.735
Sex (female)	–0.011	0.028	0.685
Liver disease severity: compensated cirrhosis	–0.051	0.031	0.094
Charlson Comorbidity index
1	–0.046	0.038	0.226
2	–0.046	0.045	0.301
3+	–0.090	0.053	0.091
Education: less than high school	–0.011	0.031	0.723
Unemployed	–0.092	0.034	0.007*
History of injection drug use	–0.004	0.032	0.907
History of mental health problem(s)	–0.106	0.032	0.001*
Setting: community	–0.024	0.032	0.450

† Wilcoxon rank-sum test